EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Quest for Outbreak Preparedness: Advancing Research Response to the Next Infectious Threat
Editorial Archive

Quest for Outbreak Preparedness: Advancing Research Response to the Next Infectious Threat

Explosive human population growth and international travel, combined with a shrinking habitat for animal species and increased interaction between humans and animals,...
Continue Reading →
Accelerating the Pace of Study Start-up
Editorial Archive

Accelerating the Pace of Study Start-up

Launching a new clinical study is an exciting stage of product development. There is tremendous hope that a new drug will cure illness or bring relief to patients. In...
Continue Reading →
Safety in the Spotlight: A Risk-based Approach to Biosimilars
Editorial Archive

Safety in the Spotlight: A Risk-based Approach to Biosimilars

Biosimilars have important cost benefits to offer the overall healthcare system, and they give access to treatment for patients with rare or very serious illnesses th...
Continue Reading →
Medical Management in Clinical Trials: A Roadmap to Operational Excellence
Editorial Archive

Medical Management in Clinical Trials: A Roadmap to Operational Excellence

The clinical research physician is a key member of any drug development team and forms the backbone for all medical and scientific aspects of the clinical research pr...
Continue Reading →
Medicinal Products for Human Use and Clinical Trials in the EU – A Changing Regulatory Landscape
Editorial Archive

Medicinal Products for Human Use and Clinical Trials in the EU – A Changing Regulatory Landscape

Bringing new drug products from early discovery, through clinical trials and into commercialisation is a challenging, costly and time-consuming process. It involves m...
Continue Reading →
Entering the Era of Cognitive Computing
Editorial Archive

Entering the Era of Cognitive Computing

The concept of digital health is not new; a pioneer in radio and publishing, Hugo Gernsback, first put forward the concept in the 1920s, proposing a device called the...
Continue Reading →
What Makes Russia an Attractive Market for Conducting Clinical Trials?
Editorial Archive

What Makes Russia an Attractive Market for Conducting Clinical Trials?

Today’s Russian clinical trial market is worth 880 million dollars and there is every expectation that it will continue to grow. If growth remains at the current rate...
Continue Reading →
A Review of FDA’s Action Plan to Proactively Reduce Prescription Opioid Abuse
Editorial Archive

A Review of FDA’s Action Plan to Proactively Reduce Prescription Opioid Abuse

The increasing rates of opioid abuse and dependence, as well as the alarming rise in the number of prescription opioid-related overdoses and deaths in the US, has cau...
Continue Reading →
FDA Issues Recommendations for Sunscreen Safety Studies
Editorial Archive

FDA Issues Recommendations for Sunscreen Safety Studies

Recent draft guidance from the US Food and Drug Administration (FDA) outlines data the agency needs, to determine whether a proposed active ingredient for over-thecou...
Continue Reading →
CDISC & CDASH – Interconnecting Clinical Programming and Clinical Data Management
Editorial Archive

CDISC & CDASH – Interconnecting Clinical Programming and Clinical Data Management

SDTM is the most stable and better understood of the CDISC Clinical Data Standards. SDTM is very prescriptive and, although there is ‘wiggle room,’ there is not as ...
Continue Reading →
Catalyst: 12th January 2026
Quotient